Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Reem S. Almaghrabi, Ali S. Omrani & Ziad A. Memish. (2017) Cytomegalovirus infection in lung transplant recipients. Expert Review of Respiratory Medicine 11:5, pages 377-383.
Read now
Read now
Dante Melendez & Raymund R Razonable. (2014) Immune-based monitoring for cytomegalovirus infection in solid organ transplantation: is it ready for clinical primetime?. Expert Review of Clinical Immunology 10:9, pages 1213-1227.
Read now
Read now
Oriol Manuel, Nancy Perrottet & Manuel Pascual. (2011) Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation. Expert Review of Anti-infective Therapy 9:11, pages 955-965.
Read now
Read now
Articles from other publishers (59)
Ella J Ariza-Heredia, Drew J Winston, Scott D Rowley, Kathleen Mullane, Pranatharthi Chandrasekar, Parameswaran Hari, Robin K Avery, Karl S Peggs, Deepali Kumar, Rajneesh Nath, Per Ljungman, Sherif B Mossad, Lynn El Haddad, Dimpy P Shah, Ying Jiang, Fareed Khawaja, Sanjeet Dadwal, Ted Blanchard & Roy F Chemaly. (2023) Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant. Open Forum Infectious Diseases 10:8.
Crossref
Crossref
Kyra Denise Zens, Daniel Llanas-Cornejo, Dominik Menges, Jan Sven Fehr, Christian Münz, Milo Alan Puhan & Anja Frei. (2023) Longitudinal humoral and cell-mediated immune responses in a population-based cohort in Zurich, Switzerland between March and June 2022 - evidence for protection against Omicron SARS-CoV-2 infection by neutralizing antibodies and spike-specific T-cell responses. International Journal of Infectious Diseases 133, pages 18-26.
Crossref
Crossref
Sarah Mafi, Marie Essig, Jean-Philippe Rerolle, Gisèle Lagathu, Romain Crochette, Véronique Brodard, Betoul Schvartz, Stephanie Gouarin, Nicolas Bouvier, Ilka Engelmann, Antoine Garstka, Céline Bressollette-Bodin, Diego Cantarovitch, Raphaële Germi, Benedicte Janbon, Christine Archimbaut, Anne-Elizabeth Heng, Françoise Garnier, Melissa Gomes-Mayeras, Anaïs Labrunie, Sébastien Hantz & Sophie Alain. (2023) Torque teno virus viremia and QuantiFERON®-CMV assay in prediction of cytomegalovirus reactivation in R+ kidney transplant recipients. Frontiers in Medicine 10.
Crossref
Crossref
Roya Sherkat, Zahra Shahshahan, Maryam Kalatehjari, Majid Yaran, Maryam Nasirian, Somayeh Najafi, NedaPari Zangeneh & SaharMemar Montazerin. (2023) Cytomegalovirus specific cell-mediated immunity status in women with preeclampsia: A case-control study. Advanced Biomedical Research 12:1, pages 10.
Crossref
Crossref
Jenny Li, Bradley J. Gardiner, Sanda Stankovic, Clare V. L. Oates, Yvonne Cristiano, Bronwyn J. Levvey, Andrew G. Brooks, Gregory I. Snell, Glen P. Westall & Lucy C. Sullivan. (2023) Cytomegalovirus Immunity Assays Predict Viremia but not Replication Within the Lung Allograft. Transplantation Direct 9:7, pages e1501.
Crossref
Crossref
Bradley J. Gardiner, Sue J. Lee, Allisa N. Robertson, Yvonne Cristiano, Gregory I. Snell, C. Orla Morrissey, Anton Y. Peleg & Glen P. Westall. (2022) Real-world experience of Quantiferon-CMV directed prophylaxis in lung transplant recipients. The Journal of Heart and Lung Transplantation 41:9, pages 1258-1267.
Crossref
Crossref
Natalia Redondo, Isabel Rodríguez-Goncer, Patricia Parra, Tamara Ruiz-Merlo, Francisco López-Medrano, Esther González, Natalia Polanco, Hernando Trujillo, Ana Hernández, Rafael San Juan, Amado Andrés, José María Aguado & Mario Fernández-Ruiz. (2022) Influence of single-nucleotide polymorphisms in TLR3 (rs3775291) and TLR9 (rs352139) on the risk of CMV infection in kidney transplant recipients. Frontiers in Immunology 13.
Crossref
Crossref
Nicolas Çuburu, Lukasz Bialkowski, Sergio M. Pontejo, Shiv K. Sethi, Alexander T. F. Bell, Rina Kim, Cynthia D. Thompson, Douglas R. Lowy & John T. Schiller. (2022) Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumors. Proceedings of the National Academy of Sciences 119:26.
Crossref
Crossref
Kritsada Pongsakornkullachart, Methee Chayakulkeeree, Attapong Vongwiwatana, Wannee Kantakamalakul, Peenida Skulratanasak & Pakpoom Phoompoung. (2022) QuantiFERON-Cytomegalovirus Assay for Prediction of Cytomegalovirus Viremia in Kidney Transplant Recipients: Study From High Cytomegalovirus Seroprevalence Country. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Nuria Tormo, Estela Giménez, María Martínez-Navarro, Eliseo Albert, David Navalpotro, Ignacio Torres, Concepción Gimeno & David Navarro. (2022) Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination. European Journal of Clinical Microbiology & Infectious Diseases 41:4, pages 657-662.
Crossref
Crossref
Norrapat Onpoaree, Anapat Sanpavat & Palittiya Sintusek. (2022) Cytomegalovirus infection in liver-transplanted children. World Journal of Hepatology 14:2, pages 338-353.
Crossref
Crossref
Sara Alonso-Álvarez, Enrique Colado, Marco A. Moro-García & Rebeca Alonso-Arias. (2021) Cytomegalovirus in Haematological Tumours. Frontiers in Immunology 12.
Crossref
Crossref
A Albasanz‐Puig, P Suanzes, J Esperalba, C Fernández, J Sellarès‐Nadal, A Torrella, B Planas, A Segura, J Burgos, E Ribera, E Cañas‐Ruano, JN García, J Navarro, A Curran, Ó Len & V Falcó. (2021) Low frequency of cytomegalovirus (CMV) disease despite high prevalence of CMV viraemia in patients with advanced HIV infection: a clinical and immunological 48‐week follow‐up study. HIV Medicine 22:8, pages 682-689.
Crossref
Crossref
Smaranda Gliga, Melanie Fiedler, Theresa Dornieden, Anne Achterfeld, Andreas Paul, Peter A. Horn, Kerstin Herzer & Monika Lindemann. (2021) Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients. Vaccines 9:2, pages 88.
Crossref
Crossref
Chris D Lauruschkat, Lukas Page, Sonja Etter, Philipp Weis, Florian Gamon, Sabrina Kraus, Hermann Einsele, Sebastian Wurster & Juergen Loeffler. (2021) T-Cell Immune Surveillance in Allogenic Stem Cell Transplant Recipients: Are Whole Blood–Based Assays Ready to Challenge ELISPOT?. Open Forum Infectious Diseases 8:1.
Crossref
Crossref
Charlotte J. Houldcroft, Sarah E. Jackson, Eleanor Y. Lim, George X. Sedikides, Emma L. Davies, Claire Atkinson, Megan McIntosh, Ester B. M. Remmerswaal, Georgina Okecha, Frederike J. Bemelman, Richard J. Stanton, Matthew Reeves & Mark R. Wills. (2020) Assessing Anti-HCMV Cell Mediated Immune Responses in Transplant Recipients and Healthy Controls Using a Novel Functional Assay. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Jorge Valle-Arroyo, Rocío Aguado, Aurora Páez-Vega, Ana B. Pérez, Rafael González, Gema Fornés, Julián Torre-Cisneros & Sara Cantisán. (2020) Lack of cytomegalovirus (CMV)-specific cell-mediated immune response using QuantiFERON-CMV assay in CMV-seropositive healthy volunteers: fact not artifact. Scientific Reports 10:1.
Crossref
Crossref
Chethan Ashokkumar, Michael Green, Kyle Soltys, Marian Michaels, George Mazariegos, Miguel Reyes‐Mugica, Brandon W. Higgs, Brianna Spishock, Madison Zaccagnini, Pradeep Sethi, Alexis Rzempoluch, Alexandra Kepler, Pam Kachmar, Lisa Remaley, Julia Winnier, Katie Jones, Kayla Moir, Tamara Fazzolare, Katherine Jenkins, Tara Hartle, Rachel Falik, Mylarappa Ningappa, Geoffrey Bond, Ajai Khanna, Armando Ganoza, Qing Sun & Rakesh Sindhi. (2019) CD154‐expressing CMV‐specific T cells associate with freedom from DNAemia and may be protective in seronegative recipients after liver or intestine transplantation. Pediatric Transplantation 24:1.
Crossref
Crossref
Marine Andreani, Laetitia Albano, Sylvia Benzaken, Elisabeth Cassuto, Ahmed Jeribi, Anne Caramella, Valérie Giordanengo, Ghislaine Bernard, Vincent Esnault & Barbara Seitz-Polski. (2020) Monitoring of CMV-Specific Cell-Mediated Immunity in Kidney Transplant Recipients With a High Risk of CMV Disease (D+/R−): A Case Series. Transplantation Proceedings 52:1, pages 204-211.
Crossref
Crossref
Marcela Rubio-Carrasquilla, Rodrigo Ochoa, Cristian Santa, Allan J. Guimarães, Luz Elena Cano & Ernesto Moreno. (2019) Identifying molecularly defined antigens for a Histoplasma capsulatum-specific interferon gamma release assay. Revista Iberoamericana de Micología 36:4, pages 186-191.
Crossref
Crossref
Aurora Paez-Vega, Sara Cantisan, José Manuel Vaquero, Elisa Vidal, Antonio Luque-Pineda, María Ángeles Lobo-Acosta, Ana Belén Pérez, Rodrigo Alonso-Moralejo, David Iturbe, Victor Monforte, Isabel Otero-Gonzalez, Amparo Pastor, Piedad Ussetti & Julian Torre-Cisneros. (2019) Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial. BMJ Open 9:8, pages e030648.
Crossref
Crossref
Mario Fernández-Ruiz, Isabel Rodríguez-Goncer, Tamara Ruiz-Merlo, Patricia Parra, Francisco López-Medrano, Amado Andrés & José María Aguado. (2019) Low 25-hydroxyvitamin D Levels and the Risk of Late CMV Infection After Kidney Transplantation: Role for CMV-specific Mediated Immunity. Transplantation 103:8, pages e216-e217.
Crossref
Crossref
Marcela Rubio-Carrasquilla, Cristian David Santa, Juan Pablo Rendón, Jorge Botero-Garcés, Allan J Guimarães, Ernesto Moreno & Luz Elena Cano. (2019) An interferon gamma release assay specific for Histoplasma capsulatum to detect asymptomatic infected individuals: A proof of concept study. Medical Mycology 57:6, pages 724-732.
Crossref
Crossref
Ping Yang, Zhen Chen, Jieqiong Zhang, Wei Li, Changlin Zhu, Ping Qiu, Yaru Quan, Xiaoyu Cui, Liyong Yuan & Chunlai Jiang. (2019) Evaluation of Varicella‐zoster virus‐specific cell‐mediated immunity by interferon‐γ Enzyme‐Linked Immunosorbent Assay in adults ≥50 years of age administered a herpes zoster vaccine. Journal of Medical Virology 91:5, pages 829-835.
Crossref
Crossref
Lynn El Haddad, Ella Ariza-Heredia, Dimpy P Shah, Ying Jiang, Ted Blanchard, Shashank S Ghantoji, Firas El Chaer, Danielle El-Haddad, Amrita Prayag, Lior Nesher, Katy Rezvani, Elizabeth Shpall & Roy F Chemaly. (2019) The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients. The Journal of Infectious Diseases 219:6, pages 898-907.
Crossref
Crossref
Bradley J Gardiner, Natalie E Nierenberg, Jennifer K Chow, Robin Ruthazer, David M Kent & David R Snydman. (2018) Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients. Clinical Infectious Diseases 67:9, pages 1395-1402.
Crossref
Crossref
Bilio Paouri, Alexandra Soldatou, Eftihia Petrakou, Maria Theodosaki, Charalampos Tsentidis, Katerina Kaisari, Christina Oikonomopoulou, Minos Matsas & Eugenios Goussetis. (2018) Quantiferon-Cytomegalovirus assay: A potentially useful tool in the evaluation of CMV-specific CD8+ T-cell reconstitution in pediatric hematopoietic stem cell transplant patients. Pediatric Transplantation 22:5, pages e13220.
Crossref
Crossref
Smaranda Gliga, Johannes Korth, Adalbert Krawczyk, Benjamin Wilde, Peter A. Horn, Oliver Witzke, Monika Lindemann & Melanie Fiedler. (2018) T-Track-CMV and QuantiFERON-CMV assays for prediction of protection from CMV reactivation in kidney transplant recipients. Journal of Clinical Virology 105, pages 91-96.
Crossref
Crossref
Rajiv Khanna. (2018) Immune Monitoring of Infectious Complications in Transplant Patients: an Important Step towards Improved Clinical Management. Journal of Clinical Microbiology 56:4.
Crossref
Crossref
Michelle K. Yong, Sharon R. Lewin & Oriol Manuel. (2018) Immune Monitoring for CMV in Transplantation. Current Infectious Disease Reports 20:4.
Crossref
Crossref
M.d.C. De Gracia-Guindo, M.d.C. Ruiz-Fuentes, P. Galindo-Sacristán, J.M. Osorio-Moratalla, N. Ruiz-Fuentes, J. Rodriguez Granger & A. Osuna-Ortega. (2018) Cytomegalovirus Infection Monitoring Based on Interferon Gamma Release Assay in Kidney Transplantation. Transplantation Proceedings 50:2, pages 578-580.
Crossref
Crossref
Fabian Schlott, Dominik Steubl, Stefanie Ameres, Andreas Moosmann, Stefan Dreher, Uwe Heemann, Volker Hösel, Dirk H. Busch & Michael Neuenhahn. (2018) Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8+ T cells. PLOS ONE 13:2, pages e0193554.
Crossref
Crossref
Adalbert Krawczyk, Jessica Ackermann, Birgit Goitowski, Rudolf Trenschel, Markus Ditschkowski, Jörg Timm, Hellmut Ottinger, Dietrich W. Beelen, Nico Grüner & Melanie Fiedler. (2018) Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR. Journal of Clinical Virology 99-100, pages 61-66.
Crossref
Crossref
Michelle K. Yong, Paul U. Cameron, Monica Slavin, C. Orla Morrissey, Krystal Bergin, Andrew Spencer, David Ritchie, Allen C. Cheng, Assia Samri, Guislaine Carcelain, Brigitte Autran & Sharon R Lewin. (2017) Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation. The Journal of Infectious Diseases 215:11, pages 1684-1694.
Crossref
Crossref
Sang Hoon Han. (2017) Immunological Prediction of Cytomegalovirus (CMV) Replication Risk in Solid Organ Transplantation Recipients: Approaches for Regulating the Targeted Anti-CMV Prevention Strategies. Infection & Chemotherapy 49:3, pages 161.
Crossref
Crossref
Gabriella Forner, Alda Saldan, Carlo Mengoli, Nadia Gussetti, Giorgio Palù & Davide Abate. (2016) Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot Assay but Not CMV QuantiFERON Assay Is a Novel Biomarker To Determine Risk of Congenital CMV Infection in Pregnant Women. Journal of Clinical Microbiology 54:8, pages 2149-2154.
Crossref
Crossref
A.V. Ibarra-Meneses, E. Carrillo, C. Sánchez, J. García-Martínez, D. López Lacomba, J.V. San Martin, F. Alves, J. Alvar & J. Moreno. (2016) Interleukin-2 as a marker for detecting asymptomatic individuals in areas where Leishmania infantum is endemic. Clinical Microbiology and Infection 22:8, pages 739.e1-739.e4.
Crossref
Crossref
A. Tarasewicz, A. Dębska-Ślizień & B. Rutkowski. (2016) Clinical Utility of QuantiFERON-Cytomegalovirus Test in Management of Kidney Transplant Recipients. Transplantation Proceedings 48:5, pages 1650-1653.
Crossref
Crossref
Oscar Len, Antonio Roman & Joan Gavaldà. 2016. Transplant Infections. Transplant Infections
167
183
.
Siddharth Sood, Craig Haifer, Lijia Yu, Julie Pavlovic, Paul J. Gow, Robert M. Jones, Kumar Visvanathan, Peter W. Angus & Adam G. Testro. (2015) Targeted individual prophylaxis offers superior risk stratification for cytomegalovirus reactivation after liver transplantation. Liver Transplantation 21:12, pages 1478-1485.
Crossref
Crossref
Sandra A. Calarota, Judith H. Aberle, Elisabeth Puchhammer-Stöckl & Fausto Baldanti. (2015) Approaches for monitoring of non virus-specific and virus-specific T-cell response in solid organ transplantation and their clinical applications. Journal of Clinical Virology 70, pages 109-119.
Crossref
Crossref
T. Schmidt, D. Schub, M. Wolf, J. Dirks, M. Ritter, S. Leyking, M. Singh, A.M. Zawada, A.-B. Blaes-Eise, U. Samuel, U. Sester & M. Sester. (2014) Comparative Analysis of Assays for Detection of Cell-Mediated Immunity Toward Cytomegalovirus and M. tuberculosis in Samples From Deceased Organ Donors. American Journal of Transplantation 14:9, pages 2159-2167.
Crossref
Crossref
Mario Fernández-Ruiz, Deepali Kumar & Atul Humar. (2014) Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation. Clinical & Translational Immunology 3:2, pages e12.
Crossref
Crossref
Jackrapong Bruminhent. (2014) Management of cytomegalovirus infection and disease in liver transplant recipients. World Journal of Hepatology 6:6, pages 370.
Crossref
Crossref
Ella J. Ariza-Heredia, Lior Nesher & Roy F. Chemaly. (2014) Cytomegalovirus diseases after hematopoietic stem cell transplantation: A mini-review. Cancer Letters 342:1, pages 1-8.
Crossref
Crossref
Oriol Manuel. (2013) Clinical Experience with Immune Monitoring for Cytomegalovirus in Solid-Organ Transplant Recipients. Current Infectious Disease Reports 15:6, pages 491-496.
Crossref
Crossref
Siok-Keen Tey, Glen A. Kennedy, Deborah Cromer, Miles P. Davenport, Susan Walker, Linda I. Jones, Tania Crough, Simon T. Durrant, James A. Morton, Jason P. Butler, Ashish K. Misra, Geoffrey R. Hill & Rajiv Khanna. (2013) Clinical Assessment of Anti-Viral CD8+ T Cell Immune Monitoring Using QuantiFERON-CMV® Assay to Identify High Risk Allogeneic Hematopoietic Stem Cell Transplant Patients with CMV Infection Complications. PLoS ONE 8:10, pages e74744.
Crossref
Crossref
L Weseslindtner, H Kerschner, D Steinacher, M Kundi, P Jaksch, B Simon, L Hatos-Agyi, A Scheed, W Klepetko & E Puchhammer-Stöckl. (2013) Association of human cytomegalovirus DNAaemia and specific granzyme B responses in lung transplant recipients. Clinical and Experimental Immunology 173:3, pages 438-443.
Crossref
Crossref
O. Manuel, S. Husain, D. Kumar, C. Zayas, S. Mawhorter, M. E. Levi, J. Kalpoe, L. Lisboa, L. Ely, D. R. Kaul, B. S. Schwartz, M. I. Morris, M. G. Ison, B. Yen-Lieberman, A. Sebastian, M. Assi & A. Humar. (2012) Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study. Clinical Infectious Diseases 56:6, pages 817-824.
Crossref
Crossref
S. Cantisán, R. Lara, M. Montejo, J. Redel, A. Rodríguez-Benot, J. Gutiérrez-Aroca, M. González-Padilla, L. Bueno, A. Rivero, R. Solana & J. Torre-Cisneros. (2013) Pretransplant Interferon-γ Secretion by CMV-Specific CD8+ T Cells Informs the Risk of CMV Replication After Transplantation. American Journal of Transplantation 13:3, pages 738-745.
Crossref
Crossref
K.E. Schoeppler, D.M. Lyu, T.J. Grazia, J.T. CrossnoJr.Jr., K.M. Vandervest & M.R. Zamora. (2013) Late-Onset Cytomegalovirus (CMV) in Lung Transplant Recipients: Can CMV Serostatus Guide the Duration of Prophylaxis?. American Journal of Transplantation 13:2, pages 376-382.
Crossref
Crossref
V.C. Emery. (2013) Human Herpesvirus Vaccines and Future Directions. American Journal of Transplantation 13, pages 79-86.
Crossref
Crossref
Elena Beam & Raymund R. Razonable. (2012) Cytomegalovirus in Solid Organ Transplantation: Epidemiology, Prevention, and Treatment. Current Infectious Disease Reports 14:6, pages 633-641.
Crossref
Crossref
L. Weseslindtner, H. Kerschner, D. Steinacher, R. Nachbagauer, M. Kundi, P. Jaksch, B. Simon, L. Hatos-Agyi, A. Scheed, W. Klepetko & E. Puchhammer-Stöckl. (2012) Prospective Analysis of Human Cytomegalovirus DNAemia and Specific CD8+ T Cell Responses in Lung Transplant Recipients. American Journal of Transplantation 12:8, pages 2172-2180.
Crossref
Crossref
María Ángeles Clari, Beatriz Muñoz-Cobo, Carlos Solano, Isabel Benet, Elisa Costa, María José Remigia, Dayana Bravo, Paula Amat & David Navarro. (2012)
Performance of the QuantiFERON-Cytomegalovirus (CMV) Assay for Detection and Estimation of the Magnitude and Functionality of the CMV-Specific Gamma Interferon-Producing CD8
+
T-Cell Response in Allogeneic Stem Cell Transplant Recipients
. Clinical and Vaccine Immunology 19:5, pages 791-796.
Crossref
Crossref
Luiz F. Lisboa, Deepali Kumar, Leticia E. Wilson & Atul Humar. (2012) Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia. Transplantation 93:2, pages 195-200.
Crossref
Crossref
Keyur Pravinchandra Patel, John Galbincea & Rajyalakshmi Luthra. 2012. Modern Clinical Molecular Techniques. Modern Clinical Molecular Techniques
261
279
.
. (2011) Current World Literature. Current Opinion in Organ Transplantation 16:6, pages 650-660.
Crossref
Crossref
Sara Cantisán Bohórquez & David Navarro Ortega. (2011) Estrategias de monitorización inmunológica para la infección por citomegalovirus. Tratamientos de base inmunológica. Enfermedades Infecciosas y Microbiología Clínica 29, pages 28-32.
Crossref
Crossref